These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Results of observation of persons with increased sensitivity to standard tuberculin]. Tabidze ShA Probl Tuberk; 1970; 48(12):15-9. PubMed ID: 5516179 [No Abstract] [Full Text] [Related]
43. A cost-benefit study of a hypertension screening and treatment program at the work setting. Hannan EL; Graham JK Inquiry; 1978 Dec; 15(4):345-48. PubMed ID: 152293 [No Abstract] [Full Text] [Related]
44. Cost-effectiveness analysis of strategies for screening prostatic cancer. Launois R Dev Health Econ Public Policy; 1992; 1():81-108. PubMed ID: 10151755 [No Abstract] [Full Text] [Related]
45. The opportunity costs of screening children for asthma. McElligott S; Polsky D J Allergy Clin Immunol; 2010 Mar; 125(3):651-2. PubMed ID: 20226299 [No Abstract] [Full Text] [Related]
46. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination. Marks SM; Dowdy DW; Menzies NA; Shete PB; Salomon JA; Parriott A; Shrestha S; Flood J; Hill AN Public Health Rep; 2020; 135(1_suppl):38S-43S. PubMed ID: 32735183 [No Abstract] [Full Text] [Related]
47. Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Verguet S; Laxminarayan R; Jamison DT Health Econ; 2015 Mar; 24(3):318-32. PubMed ID: 24497185 [TBL] [Abstract][Full Text] [Related]
48. Treatment of childhood tuberculosis. Amdekar YK Indian Pediatr; 1998 May; 35(5):491-3. PubMed ID: 10216642 [No Abstract] [Full Text] [Related]
49. [The problem of tuberculosis at present]. Ursov IG Sov Med; 1990; (11):3-7. PubMed ID: 2075519 [No Abstract] [Full Text] [Related]
50. American Thoracic Society-Center for Disease Control. Toward eradication--a contemporary tuberculosis control strategy. Am Rev Respir Dis; 1978 Sep; 118(3):641-4. PubMed ID: 707888 [No Abstract] [Full Text] [Related]
52. A normative analytic framework for development of practice guidelines for specific clinical populations. Owens DK; Nease RF Med Decis Making; 1997; 17(4):409-26. PubMed ID: 9343799 [TBL] [Abstract][Full Text] [Related]
59. Summaries for patients. The cost-effectiveness of screening for type 2 diabetes. Ann Intern Med; 2004 May; 140(9):I29. PubMed ID: 15126270 [No Abstract] [Full Text] [Related]
60. Should we screen for type 2 diabetes: Yes. Khunti K; Davies M BMJ; 2012 Jul; 345():e4514. PubMed ID: 22777029 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]